| Name | 2,4-Dichloro-5-ethylpyrimidine |
|---|---|
| Synonyms |
2,4-Dichloro-5-ethylpyrimidine
Pyrimidine, 2,4-dichloro-5-ethyl- 2,4-dichloro-5-ethyl-pyrimidine |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 245.5±20.0 °C at 760 mmHg |
| Molecular Formula | C6H6Cl2N2 |
| Molecular Weight | 177.031 |
| Flash Point | 126.0±7.4 °C |
| Exact Mass | 175.990799 |
| PSA | 25.78000 |
| LogP | 2.15 |
| Vapour Pressure | 0.0±0.5 mmHg at 25°C |
| Index of Refraction | 1.543 |
| Hazard Codes | Xi |
|---|---|
| Risk Phrases | 41 |
| Safety Phrases | 26-39 |
| RIDADR | 3261 |
| Packaging Group | Ⅱ |
| HS Code | 2933599090 |
|
~99%
34171-40-9 |
| Literature: Taisho Pharmaceutical Co. Ltd.; Arena Pharmaceuticals, Inc. Patent: EP1464335 A2, 2004 ; Location in patent: Page/Page column 329 ; EP 1464335 A2 |
|
~%
34171-40-9 |
| Literature: McIver, Edward G.; Bryans, Justin; Birchall, Kristian; Chugh, Jasveen; Drake, Thomas; Lewis, Stephen J.; Osborne, Joanne; Smiljanic-Hurley, Ela; Tsang, William; Kamal, Ahmad; Levy, Alison; Newman, Michelle; Taylor, Debra; Arthur, J. Simon C.; Clark, Kristopher; Cohen, Philip Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 23 p. 7169 - 7173,5 |
|
~%
34171-40-9 |
| Literature: McIver, Edward G.; Bryans, Justin; Birchall, Kristian; Chugh, Jasveen; Drake, Thomas; Lewis, Stephen J.; Osborne, Joanne; Smiljanic-Hurley, Ela; Tsang, William; Kamal, Ahmad; Levy, Alison; Newman, Michelle; Taylor, Debra; Arthur, J. Simon C.; Clark, Kristopher; Cohen, Philip Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 23 p. 7169 - 7173,5 |
| Precursor 3 | |
|---|---|
| DownStream 2 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |